MX2016011812A - Uso in vivo e in vitro de grafeno. - Google Patents

Uso in vivo e in vitro de grafeno.

Info

Publication number
MX2016011812A
MX2016011812A MX2016011812A MX2016011812A MX2016011812A MX 2016011812 A MX2016011812 A MX 2016011812A MX 2016011812 A MX2016011812 A MX 2016011812A MX 2016011812 A MX2016011812 A MX 2016011812A MX 2016011812 A MX2016011812 A MX 2016011812A
Authority
MX
Mexico
Prior art keywords
enclosure
environment
vivo
graphene
selected substances
Prior art date
Application number
MX2016011812A
Other languages
English (en)
Inventor
simon Sarah
B Jr Stetson John
Original Assignee
Lockheed Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lockheed Corp filed Critical Lockheed Corp
Publication of MX2016011812A publication Critical patent/MX2016011812A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00—Carbon; Compounds thereof
    • C01B32/15—Nano-sized carbon materials
    • C01B32/182—Graphene
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B2204/00—Structure or properties of graphene
    • C01B2204/20—Graphene characterized by its properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Composite Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Se describen materiales bidimensionales, particularmente materiales basados en grafeno, que tienen una pluralidad de aperturas en los mismos que pueden formarse en envolturas de varias sustancias e introducirse a un ambiente, particularmente un ambiente biológico (in vivo o in vitro). Una o más sustancias seleccionadas pueden liberarse al ambiente, una o más sustancias seleccionadas del ambiente pueden ingresar en la envoltura, una o más sustancias seleccionadas del ambiente pueden prevenir la entrada a la envoltura, una o más sustancias pueden mantenerse dentro de la envoltura, o combinaciones de las mismas. La envoltura puede, por ejemplo, permitir realizar un paradigma sensible a la respuesta. La envoltura puede, por ejemplo, proporcionar aislado inmunológico para materiales, tales como células vivas, mantenidas dentro de esta.
MX2016011812A 2014-03-12 2015-03-12 Uso in vivo e in vitro de grafeno. MX2016011812A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461951926P 2014-03-12 2014-03-12
PCT/US2015/020201 WO2015138736A1 (en) 2014-03-12 2015-03-12 In vivo and in vitro use of graphene

Publications (1)

Publication Number Publication Date
MX2016011812A true MX2016011812A (es) 2017-05-09

Family

ID=54067811

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011812A MX2016011812A (es) 2014-03-12 2015-03-12 Uso in vivo e in vitro de grafeno.

Country Status (12)

Country Link
US (1) US20150258254A1 (es)
EP (1) EP3116476A4 (es)
JP (1) JP2017516745A (es)
KR (1) KR20160132102A (es)
CN (1) CN106232103A (es)
AU (1) AU2015229296A1 (es)
CA (1) CA2942487A1 (es)
EA (1) EA201691826A1 (es)
IL (1) IL247775A0 (es)
MX (1) MX2016011812A (es)
SG (1) SG11201607584PA (es)
WO (1) WO2015138736A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
CN104245577A (zh) 2012-03-21 2014-12-24 洛克希德马丁公司 使用活化气流穿孔石墨烯的方法以及由其生产的穿孔的石墨烯
US9463421B2 (en) 2012-03-29 2016-10-11 Lockheed Martin Corporation Planar filtration and selective isolation and recovery device
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9844757B2 (en) 2014-03-12 2017-12-19 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10118130B2 (en) 2016-04-14 2018-11-06 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
US9592475B2 (en) 2013-03-12 2017-03-14 Lockheed Martin Corporation Method for forming perforated graphene with uniform aperture size
EP2969153A1 (en) 2013-03-13 2016-01-20 Lockheed Martin Corporation Nanoporous membranes and methods for making the same
US9480952B2 (en) 2013-03-14 2016-11-01 Lockheed Martin Corporation Methods for chemical reaction perforation of atomically thin materials
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
KR20160142820A (ko) * 2014-01-31 2016-12-13 록히드 마틴 코포레이션 브로드 이온 필드를 사용한 2차원 물질 천공
SG11201606287VA (en) 2014-01-31 2016-08-30 Lockheed Corp Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
JP2017534311A (ja) 2014-09-02 2017-11-24 ロッキード・マーチン・コーポレーション 二次元膜材料をベースとする血液透析膜および血液濾過膜、ならびにそれを用いた方法
AU2016303048A1 (en) 2015-08-05 2018-03-01 Lockheed Martin Corporation Perforatable sheets of graphene-based material
KR20180037991A (ko) 2015-08-06 2018-04-13 록히드 마틴 코포레이션 그래핀의 나노 입자 변형 및 천공
JP2018521806A (ja) 2015-08-06 2018-08-09 ロッキード・マーチン・コーポレーション 低細胞毒性である移植可能なグラフェン膜
EP3331585A4 (en) * 2015-08-06 2019-05-15 Lockheed Martin Corporation IMPLANTABLE GRAPHIC MEMBRANES WITH LOW CYTOTOXICITY
WO2017180135A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Membranes with tunable selectivity
WO2017180134A1 (en) * 2016-04-14 2017-10-19 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
JP2019519756A (ja) 2016-04-14 2019-07-11 ロッキード・マーチン・コーポレーション 欠陥形成または欠陥修復をその場で監視して制御する方法
SG11201809016QA (en) 2016-04-14 2018-11-29 Lockheed Corp Selective interfacial mitigation of graphene defects
WO2017180137A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Method for treating graphene sheets for large-scale transfer using free-float method
GB201608315D0 (en) * 2016-05-12 2016-06-29 Grafmed Device for delivering medicaments or active ingredients
KR102108921B1 (ko) * 2018-09-06 2020-05-11 영남대학교 산학협력단 플러그 앤 플레이 타입 나노화 장치 및 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2187417A (en) * 1938-12-30 1940-01-16 Ralph N Doble Tea bag, coffee bag, and the like
US7674477B1 (en) * 2003-11-06 2010-03-09 University Of Notre Dame Du Lac Bone and tissue scaffolding for delivery of therapeutic agents
US8246917B2 (en) * 2006-06-23 2012-08-21 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US8187255B2 (en) * 2007-02-02 2012-05-29 Boston Scientific Scimed, Inc. Medical devices having nanoporous coatings for controlled therapeutic agent delivery
WO2009132173A2 (en) * 2008-04-25 2009-10-29 Encapsulife, Inc. Immunoisolation patch system for cellular transplantation
EP4176888A1 (en) * 2008-11-14 2023-05-10 ViaCyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
US20110270168A1 (en) * 2010-05-03 2011-11-03 Izhar Halahmi Releasing device for administering a bio-active agent
WO2012005857A1 (en) * 2010-06-08 2012-01-12 President And Fellows Of Harvard College Nanopore device with graphene supported artificial lipid membrane
US9028663B2 (en) * 2012-03-21 2015-05-12 Lockheed Martin Corporation Molecular separation device

Also Published As

Publication number Publication date
SG11201607584PA (en) 2016-10-28
EA201691826A1 (ru) 2017-02-28
KR20160132102A (ko) 2016-11-16
AU2015229296A2 (en) 2017-07-20
CN106232103A (zh) 2016-12-14
AU2015229296A1 (en) 2016-10-27
CA2942487A1 (en) 2015-09-17
IL247775A0 (en) 2016-11-30
EP3116476A4 (en) 2017-11-08
EP3116476A1 (en) 2017-01-18
US20150258254A1 (en) 2015-09-17
JP2017516745A (ja) 2017-06-22
WO2015138736A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
MX2016011812A (es) Uso in vivo e in vitro de grafeno.
MX2018001556A (es) Membranas implantables de grafeno con baja citotoxicidad.
IL267616A (en) Immunologically engineered pluripotent cells
IL251576A0 (en) Methods and compositions for creating or maintaining multifunctional cells
MX2023005262A (es) Composiciones y metodos relacionados con particulas depuradoras.
PT3233493T (pt) Biotinta nanofibrilar de celulose para bioimpressão em 3d para cultura celular, aplicações de engenharia de tecidos e medicina regenerativa
RS53886B1 (en) APPLIANCES AND PROCEDURES FOR CELL CULTIVATION
TW201614904A (en) Methods of forming biocompatible rechargable energization elements for biomedical devices
EP3325143A4 (en) MAGNETIC HYDROPHOBIC POROUS GRAPHIC SPONGE FOR ENVIRONMENTAL AND BIOLOGICAL / MEDICAL APPLICATIONS
EA201790177A1 (ru) Агротехнические способы
IL269932B (en) Hydrogel for cell culture and biomedical applications
MY181994A (en) Immuno-modulatory progenitor (imp) cell
GB201602142D0 (en) Biological methods and materials for use therein
MX2015018035A (es) Metodos para predecir respuestas a sustancias quimicas o biologicas.
GB201512600D0 (en) Cell culture, transport and investigation
NZ731103A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
UY35804A (es) Recubrimiento de alginato para tratamiento de semillas
AR108134A1 (es) Diferenciación de células madre pluripotentes en células del endodermo del intestino medio
HRP20181352T1 (hr) Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu
IL260081B (en) Compounds with low molecular weight to inhibit the activity of chemokines and/or to inhibit the growth of cancer cells
CO2018007573A2 (es) Tratamiento in situ de semillas en el surco
MY165444A (en) Thawing vessel for biological products
EP3126037A4 (en) Active transport of charged molecules into, within, and/or from charged matrices
EP3220996A4 (en) Instruments and methods for loading cells into implantable devices
EP3307873A4 (en) Hematopoietic cells and methods of using and generating the same